[Zaditen: a pharmacologic and therapeutic profile].
The pharmacological properties of Zaditen include the inhibition of mediator release, the inhibition of bronchial hyperreactivity and the suppression of beta-adrenergic tachyphylaxis. Its therapeutic efficacy is characterized by a reduction of the severity and the variability of asthma combined with a decrease of bronchodilator use and a progressive improvement of pulmonary function. The normalization of physical activities and sleep disturbances, less absenteeism at work or school, witness a better quality of life. Long term safety and tolerance are excellent.